One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Category:Laboratory > Laboratory Consumable > Medium Product Name:HIPP-T006 serum-free medium for lymphocytes CAS No.:N/A Price(USD):Negotiable Company:Shanghai BioEngine Sci-Tech Co., Ltd.
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Serum-free media especially developed for lymphocyte culture in vitro
Since the end of the last century, the research team of BioEngine has been engaged in the research of in vitro culture of immune cells and has published many academic papers. The team began the independent development of serum-free media for lymphocyte culture in vitro in 2015. HIPP-T006 Lymphocyte serum-free medium is a product free of serum with a limited chemical composition developed by BioEngine according to the characteristics of blood cell growth and differentiation with independent intellectual property rights. HIPP-T006 has a clear composition and uses high-quality standard raw materials to ensure maximum safety and reliability of the production process. It is suitable for in vitro serum-free/reduced culture and amplification of primary cells such as PBMC, T cells, and NK cells as well as cell lines such as NK-92, NK-92MI, K562, and Jurakt.
Features
Xeno-free, contains no growth factors, synthetic activators, or undefined components
Universality and flexibility: Applicable for the culture of T-cell, NK cell, CAR-T, CIK, CAR-NK, hematopoietic stem cells and other types of cell lines (NK-92, NK-92MI, K562, Jurkat, etc.)
Allowing for direct use in culturing cell lines without the addition of serum, plasma or serum substitutes, to achieve the same culture results as serum-containing media
Better than similar domestic and foreign brands under the same conditions in culturing primary cells
Advantages
Maximum viable cell density up to 5×106 cells/ml under static culture conditions;
Manufactured under the cGMP guidelines and ISO13485 quality system, meet regulatory requirements in different countries;
Use of fully automatic filling lines, to meet the needs of the customer’s dosage and ensure the timeliness of supply and inter-batch stability;
A direct substitute for similar domestic and foreign brands, producing better culture results than their counterparts;
Comprehensive set of DMR documents for audit.
Audited Supplier
Pharma Sources Insight January 2025
